Pharma Stocks
-
Roche (SWX:ROP) Wins FDA Clearance And EU Backing For Two Key Products
Roche Holding (SWX:ROP) received FDA 510(k) clearance for its cobas BV/CV molecular diagnostic assay, expanding its sexual health testing portfolio…
Read More » -
Forget Weight Loss Drugs: Here’s Another Reason to Buy Eli Lilly Stock
Eli Lilly (LLY -0.21%) brought in $19.8 billion in revenue in the first quarter of 2026, and most of it…
Read More » -
Is Camurus (OM:CAMX) Still Undervalued On Its FDA CAM2029 Milestone?
Camurus (OM:CAMX) is back in focus after the US Food and Drug Administration accepted the resubmitted New Drug Application for…
Read More » -
Lexicon Pharmaceuticals (LXRX) Nears Key HCM Readout On An Undervalued Narrative
Lexicon Pharmaceuticals (LXRX) recently completed patient randomization in its pivotal Phase 3 SONATA HCM trial of sotagliflozin for obstructive and…
Read More » -
How Investors Are Reacting To Supernus Pharmaceuticals (SUPN) Positive Earnings ESP And Renewed Beat Expectations
In the lead-up to its early August 2026 earnings release, Supernus Pharmaceuticals attracted attention after analysts highlighted its positive Earnings…
Read More » -
Are Ananda Pharma (LSE:ANA) And Celadon Pharmaceuticals (LSE:CEL) Keeping UK Cannabis Stocks On Watch?
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks
Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks The end of the…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 30, 2026)
Zealand Pharma Company announcement No. 35 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 30, 2026)…
Read More » -
London Stocks Gain as US-Iran Pause & Earnings Boost Market Sentiment
London Stocks Climb as US-Iran Pause and Earnings Spur Investor Optimism FTSE Indices React to Geopolitical Tensions and Earnings Reports…
Read More » -
Roche stock trades steadily as diagnostics and pharma revenue support valuation
Roche Holding AG (ISIN CH0012032048) remains a core name in global healthcare, with Roche stock representing a diversified exposure to…
Read More »